250 related articles for article (PubMed ID: 30934130)
1. Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors.
Stolz A; Navarro V; Hayashi PH; Fontana RJ; Barnhart HX; Gu J; Chalasani NP; Vega MM; Bonkovsky HL; Seeff LB; Serrano J; Avula B; Khan IA; Cirulli ET; Kleiner DE; Hoofnagle JH;
Aliment Pharmacol Ther; 2019 May; 49(9):1195-1204. PubMed ID: 30934130
[TBL] [Abstract][Full Text] [Related]
2. Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1/ABCB11 mutations?
El Sherrif Y; Potts JR; Howard MR; Barnardo A; Cairns S; Knisely AS; Verma S
Liver Int; 2013 Sep; 33(8):1266-70. PubMed ID: 23750872
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.
Bonkovsky HL; Kleiner DE; Gu J; Odin JA; Russo MW; Navarro VM; Fontana RJ; Ghabril MS; Barnhart H; Hoofnagle JH;
Hepatology; 2017 Apr; 65(4):1267-1277. PubMed ID: 27981596
[TBL] [Abstract][Full Text] [Related]
4. Liver Injury Associated with Sporting Activities.
Hassan A; Fontana RJ
Semin Liver Dis; 2018 Nov; 38(4):357-365. PubMed ID: 30357773
[TBL] [Abstract][Full Text] [Related]
5. Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry.
Medina-Caliz I; Garcia-Cortes M; Gonzalez-Jimenez A; Cabello MR; Robles-Diaz M; Sanabria-Cabrera J; Sanjuan-Jimenez R; Ortega-Alonso A; García-Muñoz B; Moreno I; Jimenez-Perez M; Fernandez MC; Ginés P; Prieto M; Conde I; Hallal H; Soriano G; Roman E; Castiella A; Blanco-Reina E; Montes MR; Quiros-Cano M; Martin-Reyes F; Lucena MI; Andrade RJ;
Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1495-1502. PubMed ID: 29307848
[TBL] [Abstract][Full Text] [Related]
6. Hepatotoxicity associated with dietary energy supplements: use and abuse by young athletes.
Avelar-Escobar G; Méndez-Navarro J; Ortiz-Olvera NX; Castellanos G; Ramos R; Gallardo-Cabrera VE; Vargas-Alemán Jde J; Díaz de León O; Rodríguez EV; Dehesa-Violante M
Ann Hepatol; 2012; 11(4):564-9. PubMed ID: 22700641
[TBL] [Abstract][Full Text] [Related]
7. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.
Dröge C; Bonus M; Baumann U; Klindt C; Lainka E; Kathemann S; Brinkert F; Grabhorn E; Pfister ED; Wenning D; Fichtner A; Gotthardt DN; Weiss KH; McKiernan P; Puri RD; Verma IC; Kluge S; Gohlke H; Schmitt L; Kubitz R; Häussinger D; Keitel V
J Hepatol; 2017 Dec; 67(6):1253-1264. PubMed ID: 28733223
[TBL] [Abstract][Full Text] [Related]
8. Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.
Vitale G; Gitto S; Raimondi F; Mattiaccio A; Mantovani V; Vukotic R; D'Errico A; Seri M; Russell RB; Andreone P
J Gastroenterol; 2018 Aug; 53(8):945-958. PubMed ID: 29238877
[TBL] [Abstract][Full Text] [Related]
9. Cholestatic liver injury associated with dietary supplements: a report of five cases in active duty service members.
Peterson BR; DeRoche TC; Huber AR; Shields WW
Mil Med; 2013 Oct; 178(10):e1168-71. PubMed ID: 24083935
[TBL] [Abstract][Full Text] [Related]
10. [Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation].
Jmelnitzky AC; Guidi M; Bologna A; Viola M; Soccini C; Barbero R; Belloni P; Apraiz M
Acta Gastroenterol Latinoam; 2000; 30(2):77-84. PubMed ID: 10925723
[TBL] [Abstract][Full Text] [Related]
11. Beyond an Obvious Cause of Cholestasis in a Toddler: Compound Heterozygosity for
Fotoulaki M; Giza S; Jirsa M; Grammatikopoulos T; Miquel R; Hytiroglou P; Tsitouridis I; Knisely AS
Pediatrics; 2019 May; 143(5):. PubMed ID: 31015375
[TBL] [Abstract][Full Text] [Related]
12. Hepatotoxicity associated with dietary supplements containing anabolic steroids.
Kafrouni MI; Anders RA; Verma S
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):809-12. PubMed ID: 17509944
[TBL] [Abstract][Full Text] [Related]
13. Clinical and histologic features of Azathioprine-induced hepatotoxicity.
Siramolpiwat S; Sakonlaya D
Scand J Gastroenterol; 2017 Aug; 52(8):876-880. PubMed ID: 28388864
[TBL] [Abstract][Full Text] [Related]
14. Cholestatic liver injury secondary to artemisinin.
Kumar S
Hepatology; 2015 Sep; 62(3):973-4. PubMed ID: 25980398
[No Abstract] [Full Text] [Related]
15. Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK(®) Weight Loss Products: Results from the DILIN Prospective Study.
Zheng EX; Rossi S; Fontana RJ; Vuppalanchi R; Hoofnagle JH; Khan I; Navarro VJ
Drug Saf; 2016 Aug; 39(8):749-54. PubMed ID: 27189593
[TBL] [Abstract][Full Text] [Related]
16. Mifepristone induced liver injury in a patient with Cushing syndrome: a case report and review of the literature.
Ault TA; Braxton DR; Watson RA; Marcus AO; Fong TL
J Med Case Rep; 2023 Feb; 17(1):33. PubMed ID: 36732814
[TBL] [Abstract][Full Text] [Related]
17. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.
Navarro VJ; Barnhart H; Bonkovsky HL; Davern T; Fontana RJ; Grant L; Reddy KR; Seeff LB; Serrano J; Sherker AH; Stolz A; Talwalkar J; Vega M; Vuppalanchi R
Hepatology; 2014 Oct; 60(4):1399-408. PubMed ID: 25043597
[TBL] [Abstract][Full Text] [Related]
18. Cholestasis Linked to Bodybuilding Supplements: Exploring the Risks of Contamination.
Matusak M; Aljabban J; Wirtz M; Agni R; Spengler E
Case Reports Hepatol; 2024; 2024():5112461. PubMed ID: 38826497
[TBL] [Abstract][Full Text] [Related]
19. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced cholestasis.
Velayudham LS; Farrell GC
Expert Opin Drug Saf; 2003 May; 2(3):287-304. PubMed ID: 12904107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
